| Formulating poorly water soluble drugs RO Williams III, AB Watts, DA Miller Springer, 2012 | 195 | 2012 |
| Current therapies and technological advances in aqueous aerosol drug delivery AB Watts, JT McConville, RO Williams III Drug development and industrial pharmacy 34 (9), 913-922, 2008 | 125 | 2008 |
| Formulation and device design to increase nose to brain drug delivery ZN Warnken, HDC Smyth, AB Watts, S Weitman, JG Kuhn, RO Williams III Journal of Drug Delivery Science and Technology 35, 213-222, 2016 | 109 | 2016 |
| The manufacture and characterisation of hot-melt extruded enteric tablets GP Andrews, DS Jones, OA Diak, CP McCoy, AB Watts, JW McGinity European journal of pharmaceutics and Biopharmaceutics 69 (1), 264-273, 2008 | 106 | 2008 |
| An update on coating/manufacturing techniques of microneedles TN Tarbox, AB Watts, Z Cui, RO Williams Drug delivery and translational research 8, 1828-1843, 2018 | 87 | 2018 |
| The impact of pulmonary diseases on the fate of inhaled medicines—A review YB Wang, AB Watts, JI Peters, RO Williams III International journal of pharmaceutics 461 (1-2), 112-128, 2014 | 73 | 2014 |
| Delivery technologies for orally inhaled products: an update C Moon, HDC Smyth, AB Watts, RO Williams III AAPS PharmSciTech 20 (3), 117, 2019 | 69 | 2019 |
| Respirable Low-Density Microparticles Formed In Situ from Aerosolized Brittle Matrices AB Watts, YB Wang, KP Johnston, RO Williams Pharmaceutical Research, 1-13, 2013 | 65 | 2013 |
| Caveolin-1–derived peptide limits development of pulmonary fibrosis AS Marudamuthu, YP Bhandary, L Fan, V Radhakrishnan, BA MacKenzie, ... Science translational medicine 11 (522), eaat2848, 2019 | 64 | 2019 |
| Manufacturing and ambient stability of shelf freeze dried bacteriophage powder formulations Y Zhang, X Peng, H Zhang, AB Watts, D Ghosh International journal of pharmaceutics 542 (1-2), 1-7, 2018 | 55 | 2018 |
| Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats SR Carvalho, AB Watts, JI Peters, S Liu, S Hengsawas, ... European Journal of Pharmaceutics and Biopharmaceutics 88 (1), 136-147, 2014 | 55 | 2014 |
| In Vitro and In Vivo Performance of Dry Powder Inhalation Formulations: Comparison of Particles Prepared by Thin Film Freezing and Micronization YB Wang, AB Watts, JI Peters, S Liu, A Batra, RO Williams Aaps Pharmscitech 15, 981-993, 2014 | 55 | 2014 |
| Oxaliplatin Pt (IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents G Thiabaud, G He, S Sen, KA Shelton, WB Baze, L Segura, J Alaniz, ... Proceedings of the National Academy of Sciences 117 (13), 7021-7029, 2020 | 51 | 2020 |
| Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit® L 100-55 D Sauer, AB Watts, LB Coots, WC Zheng, JW McGinity International Journal of Pharmaceutics 367 (1-2), 20-28, 2009 | 48 | 2009 |
| Methods and compositions for disease treatment using inhalation DA Byron, AB Watts, RO Cook, M Aydin US Patent App. 13/246,686, 2012 | 39 | 2012 |
| Enhanced aerosolization of high potency nanoaggregates of voriconazole by dry powder inhalation C Moon, AB Watts, X Lu, Y Su, RO Williams III Molecular pharmaceutics 16 (5), 1799-1812, 2019 | 37 | 2019 |
| Characterization and pharmacokinetic analysis of tacrolimus dispersion for nebulization in a lung transplanted rodent model AB Watts, AM Cline, AR Saad, SB Johnson, JI Peters, RO Williams III International journal of pharmaceutics 384 (1-2), 46-52, 2010 | 31 | 2010 |
| Compositions and methods of making brittle-matrix particles through blister pack freezing KP Johnston, J Engstrom, J Rowe, AB Watts, RO Williams III US Patent 10,092,512, 2018 | 28 | 2018 |
| Nanoparticles for pulmonary delivery AB Watts, RO Williams Controlled pulmonary drug delivery, 335-366, 2011 | 27 | 2011 |
| Compositions and methods of making brittle-matrix particles through blister pack freezing KP Johnston, J Engstrom, J Rowe, AB Watts, RO Williams III US Patent 10,434,062, 2019 | 24 | 2019 |
Javier O. MoralesSchool of Chemical and Pharmaceutical Sciences, University of ChileVerified email at ciq.uchile.cl
